Are mesenchymal stem cells able to manage cytokine storm in COVID-19 patients? A review of recent studies

The Covid-19 disease has recently become one of the biggest challenges globally, and there is still no specific medication. Findings showed the immune system in severe Covid-19 patients loses regulatory control of pro-inflammatory cytokines, especially IL-6 production, called the “Cytokine storm” pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaffash Farkhad, Najmeh, Reihani, Hamidreza, sedaghat, Alireza, Moghadam, Amir Adhami, Moghadam, Ahmad Bagheri, Tavakol-Afshari, Jalil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Regenerative Medicine 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185247/
https://www.ncbi.nlm.nih.gov/pubmed/34124322
http://dx.doi.org/10.1016/j.reth.2021.05.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185247/
https://www.ncbi.nlm.nih.gov/pubmed/34124322
http://dx.doi.org/10.1016/j.reth.2021.05.007

Ejemplares similares